Skip to main content
OpenTrials
Completed

NCT Number: NCT03885167

Identification of Biomarkers in Spinocerebellar Ataxia 3

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Participants will undergo a SARA exam, a lumbar puncture and a blood draw. A lumbar puncture is a procedure in which a small amount of the spinal fluid that surrounds the brain and spinal cord is removed by inserting a needle in the lower back. Participants will be asked not to eat or drink anything (water is acceptable) for at least 6 hours before the lumbar puncture visit. For this procedure, participants will be positioned lying on their side and curled up in a ball, or sitting up and bent forward, whichever is easier. Cushions will be used to enhance comfort. The lower back region will be cleaned and disinfected with an antiseptic iodine solution. The doctor will inject local anesthetic (lidocaine, 1%) into the skin of the lower back. This may produce a transient, mild burning sensation. A very small needle will be introduced into the skin and moved into fluid-filled space around the spinal nerves coming from the spinal cord. This may produce a pressure sensation. Approximately 2 tablespoons approximately 30 ml) of fluid will be collected. The needle will be removed and a band-aid applied over the needle insertion site. Participants will be asked to remain stationary, lying on flat for about ½ hour on a bed in the research clinic. Participants will be given something to eat and drink before leaving. Strenuous physical activity should be avoided for the next 24 hours. This includes lifting, bending, doing housework and gardening, or doing exercise such as jogging or bicycle riding. The SARA (Scale for the Assessment and Rating of Ataxia) exam is a clinical scale that assesses a range of different impairments in cerebellar ataxia. The scale is made up of 8 items related to gait, stance, sitting, speech, fingerchase test, nose-finger test, fast alternating movements and heel-shin test, and takes approximately 15 minutes to complete.

The study also involves a single collection of about 3.5 tablespoons (approximately 50 ml) of blood. This blood draw may take place during a regularly scheduled visit to the neurology clinic or at the research appointment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

•Confirmed Genetic Testing of SCA3 or Healthy Volunteers

Exclusion criteria

  • People with:
  • unstable thyroid
  • unstable intestinal/stomach issues
  • unstable heart issues
  • unstable liver issues
  • unstable kidney issues
  • unstable lung issues
  • unstable hormone issues
  • unstable mental disorders at screening
  • a tumor or evidence of having a tumor
  • a chronic infection or any severe acute infection within 3 months prior to screening
  • People who:
  • Take anti-coagulants and NSAIDs
  • Have started any investigational medications in the last month
  • Women who are pregnant or breast feeding

Treatment and study plan

Specimen Collection

Other

No interventions take place as part of study participation- only specimen collection occurs for both cohorts.

Primary outcomes

  1. Change in Ataxin 3 Levels in Cerebrospinal Fluid Specimens

    Time frame: 4 Hours

    A lumbar puncture is performed to collect CSF.

  2. Change in Ataxin 3 Levels in Blood Plasma Specimens

    Time frame: 4 Hours

    A single blood draw is completed.

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Institutes of Health (NIH)

Registry information

Acronym: SCA3

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Mar 21, 2019
Registry last updated
Nov 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.